ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,444,483, issued on Oct. 14, was assigned to PERSONAL GENOME DIAGNOSTICS INC. (Baltimore).

"Qualification of sequencing instruments and reagents for use in molecular diagnostic methods" was invented by Samuel V. Angiuoli (Baltimore) and David Riley (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Presented herein are techniques for qualifying, checking and monitoring the use of diagnostic apparatuses and reagents, such as sequencing apparatuses and reagents, to ensure performance and quality of diagnostic methods. In one aspect, a system is provided for determining whether a sequencing run is a qualification run. The system includes a memory con...